This Government Contract opportunity from Department Of Defense was posted on June 12, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
BALB/cJ and C57BL/6J Mice to Support Different Infection Models
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Naval Medical Research Command intends to award a Blanket Purchase Agreement to Charles River Laboratories and The Jackson Laboratory for the continuous supply of up to 5,160 specific-pathogen-free laboratory mice, specifically female BALB/cJ and C57BL/6J strains aged 49 to 56 days and weighing 12 to 16 grams. These animals must be free from infectious diseases and must not have received any systemic or topical antimicrobials to ensure consistency with ongoing and planned in vivo infection studies scheduled between August 2026 and August 2027. Due to the critical need to preserve established phenotypic and genotypic baselines from prior research, sourcing from any vendor other than these two approved sources would compromise data integrity and invalidate historical results. The procurement is being conducted under a single-source authority as permitted by FAR 13.106-1(b)(1) and does not exceed the Simplified Acquisition Threshold. While this notice is not a competitive solicitation, any organization capable of providing the exact same genetic strains with equivalent SPF status, antimicrobial-free guarantees, and Walter Reed Army Institute of Research approval may submit a written Capability Statement by June 19, 2026, to the designated point of contact. The submission must include verifiable proof of strain authenticity, regulatory approval, and compliance with all health and containment standards. The government reserves the right to proceed without competition based on the responses received, and the animals will be delivered on an indefinite-delivery basis to support approximately forty-three research experiments across the contract period, all to be performed at the designated location in Silver Spring, Maryland.
General Info
Agency
NAICS
Place of Performance
Silver Spring, MD, 20910, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Description: The Combat Wound Infections Division (CWID) at Naval Medical Research Command (NMRC), intends to award a Blanket Purchase Agreement (BPA) to Charles River Laboratories (CRL) and The Jackson Laboratory (JAX) under the authority of FAR 13.106-1(b)(1), “Soliciting from a Single Source” for purchases not exceeding the Simplified Acquisition Threshold (SAT).The Naval Medical Research Command (NMRC) requires a continuous, flexible supply of up to 5,160 specific-pathogen-free (SPF) laboratory research mice. The requirement consists of female BALB/cJ and C57BL/6J strains, aged 49–56 days, and weighing 12–16 grams. The vendor must guarantee that all models are free from infectious diseases and have not received any prior systemic or topical antimicrobials. Delivery is required on a indefinite-delivery basis to support approximately forty-three (43) in vivo experiments scheduled between August 2026 and August 2027. Because CRL and JAX are approved by Walter Reed Army Institute of Research and planned studies are continuations of ongoing research, study baselines and control determinations have already been established using CRL BALB/cJ and JAX C57BL/6J mice, it is critical to ensure the animals are procured from these exact sources. Sourcing from alternative breeders would introduce unacceptable phenotypic and genotypic variation into the upcoming studies, which would invalidate historical data and jeopardize the integrity of the research.
This notice of intent is not a request for competitive proposals. However, any firm that believes it can meet this requirement without introducing the aforementioned phenotypic/genotypic variation to the established baselines may submit a written Capability Statement. Responses must include:
- Evidence of the ability to provide the exact genetic strains (BALB/cJ C57BL/6J).
- Evidence that they have been approved by Walter Reed Army Institute of Research.
- Confirmation of the ability to meet the SPF and “antimicrobial-free” guarantees.
Responses must be submitted to the Contracting Officer at priscilla.v.harrison.civ@health.mil no later than June 19, 2026.
A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government.
More opportunities from Department Of Defense
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS